Ethics approval and consent to participate
Cancer
CANCER
POETIC was approved by the London South-East Research Ethics Committee (reference number 08/H1102/37). All patients provided written informed consent. The Clinical Trials and Statistics Unit at The Institute of Cancer Research, London, UK (ICR-CTSU), had overall responsibility for trial and data management.